middle.news
Artrya Enlists Ascension to Boost AI Heart Disease Study in US
9:37am on Thursday 13th of November, 2025 AEDT
•
Healthcare
Read Story
Artrya Enlists Ascension to Boost AI Heart Disease Study in US
9:37am on Thursday 13th of November, 2025 AEDT
Key Points
Ascension joins SAPPHIRE Study as fourth major US healthcare system
Study to assess Artrya’s Salix AI platform and Plaque Dispersion Score
Ascension operates 94 hospitals across 16 US states and DC
SAPPHIRE Study targets earlier detection of coronary artery disease
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Artrya (ASX:AYA)
OPEN ARTICLE